The challenge of regulating anticoagulant drugs: Focus on warfarin

American Heart Journal

Volumn 149, Issue 1 SUPPL., 2005, Pages

  Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; FATTY ACID BINDING PROTEIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; VITAMIN K GROUP; WARFARIN; XIMELAGATRAN;

ANTICOAGULATION; BLOOD CLOTTING; CLINICAL TRIAL; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; THROMBIN TIME;

EID: 10944261270     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.10.021     Document Type: Article

References (37)

1. H. Dam Hemmorrhages in chicks reared on artificial diets. A new deficiency disease Nature (London) 133 1934 909 910
2. H. Dam Antihaemorrhagic vitamin of chick Biochem. J. 29 1935 1273 1285
3. H.A. Cambell, and K.P. Link Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent J. Biol. Chem. 138 1941 21 33
4. H.R. Butt, E.V. Allen, and J.L. Bollman A preparation from spoiled sweet clover [3,3′-methylene-bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: preliminary report of experimental and clinical studies Proc. Staff Meet. Mayo Clin. 16 1941 388 395
5. A.J. Quick The prothrombin time in haemophilia and in obstructive jaundice J. Biol. Chem. 109 1935 73 74
6. J. Stenflo Vitamin K and the biosynthesis of prothrombin. IV. Isolation of peptides containing prosthetic groups from normal prothrombin and the corresponding peptides from dicoumarol-induced prothrombin J. Biol. Chem. 249 1974 5527 5535
7. K.G. Mann Thrombin formation Chest 124 2003 4S 10S
8. K. Brummel-Ziedins, T. Orfeo, and N.S. Jenny Blood coagulation and fibrinolysis Wintrobe's Clinical Hematology 2003 677 774
9. E.G. Bovill, O.P. Malhotra, and K.G. Mann Mechanisms of vitamin K antagonism Bailliere's Clinical Haematology 1990 555 581
10. M. Huang, A.C. Rigby, and X. Morelli Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins Nat. Struct. Biol. 10 2003 751 756
11. K.G. Mann, R.J. Jenny, and S. Krishnaswamy Cofactor proteins in the assembly and expression of blood clotting enzyme complexes Annu. Rev. Biochem. 57 1988 915 956
12. Y. Nemerson Tissue factor and hemostasis Blood 71 1988 1 8
13. K.G. Mann, M.E. Nesheim, and W.R. Church Surface-dependent reactions of the vitamin K-dependent enzyme complexes Blood 76 1990 1 16
14. C.T. Esmon The roles of protein C and thrombomodulin in the regulation of blood coagulation J. Biol. Chem. 264 1989 4743 4746
15. E.W. Davie, and O.D. Ratnoff Waterfall sequence for intrinsic blood clotting Science 145 1964 1310 1312
16. R.G. McFarlane An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier Nature 202 1964 498 499
17. G.J. Broze Jr. Tissue factor pathway inhibitor Thromb. Haemost. 74 1995 90 93
18. P.S. Damus, and R.D. Rosenberg Antithrombin-heparin cofactor Methods Enzymol. 45 1976 653 669
19. K.G. Mann, K. Brummel, and S. Butenas What is all that thrombin for? J. Thromb. Haemost. 1 2003 1504 1514
20. K.E. Brummel, S.G. Paradis, and S. Butenas Thrombin functions during tissue factor-induced blood coagulation Blood 100 2002 148 152
21. Y.C. Chan, D. Valenti, and A.O. Mansfield Warfarin induced skin necrosis Br. J. Surg. 87 2000 266 272
22. A.M. van den Besselaar International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing J. Heart Valve Dis. 2 1993 42 52
23. D.M. Adcock, and S. Duff Enhanced standardization of the International Normalized Ratio through the use of plasma calibrants: a concise review Blood Coagul. Fibrinolysis 11 2000 583 590
24. E.K. Spicer, R. Horton, and L. Bloem Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA Proc. Natl. Acad. Sci. USA 84 1987 5148 5152
25. A. Rehemtulla, M. Pepe, and T.S. Edgington High level expression of recombinant human tissue factor in Chinese hamster ovary cells as a human thromboplastin Thromb. Haemost. 65 1991 521 527
26. K.M. Cawthern, C. van't Veer, and J.B. Lock Blood coagulation in hemophilia A and hemophilia C Blood 91 1998 4581 4592
27. F. Markwardt Hirudin as alternative anticoagulant: a historical review Semin. Thromb. Hemost. 28 2002 405 414
28. T.E. Adams, S.J. Everse, and K.G. Mann Predicting the pharmacology of thrombin inhibitors J. Thromb. Haemost. 1 2003 1024 1027
29. J.M. Maraganore, P. Bourdon, and J. Jablonski Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin Biochemistry 29 1990 7095 7101
30. A.M. Lincoff, J.A. Bittl, and R.A. Harrington Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
31. T.C. Sarich, M. Wolzt, and U.G. Eriksson Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects J. Am. Coll. Cardiol. 41 2003 557 564
32. C.W. Francis, B.L. Davidson, and S.D. Berkowitz Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial Ann. Intern. Med. 137 2002 648 655
33. A.Y. Lee, and G.P. Vlasuk Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor J. Intern. Med. 254 2003 313 321
34. G.Z. Feuerstein, J.R. Toomey, and R. Valocik An inhibitory anti-factor IX antibody effectively reduces thrombus formation in a rat model of venous thrombosis Thromb. Haemost. 82 1999 1443 1445
35. C.E. Hagemeyer, I. Tomic, and P. Jaminet Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide Thromb. Haemost. 92 2004 47 53
36. K.A. Bauer Fondaparinux: a new synthetic and selective inhibitor of Factor Xa Best Pract. Res. Clin. Haematol. 17 2004 89 104
37. A. Betz, G.P. Vlasuk, and P.W. Bergum Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa Biochemistry 36 1997 181 191